INHIBITION OF LARGE JOINT DESTRUCTION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB

被引：0
|
作者：
Hirano, Y. [1 ]
Hattori, K. [1 ]
Yamada, R. [1 ]
机构：
[1] Toyohashi Municipal Hosp, Rheumatol, Toyohashi, Aichi, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.1863
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0477
引用
收藏
页码：1399 / 1400
页数：2
相关论文
共 50 条
  • [21] [18F]fluorodeoxyglucose uptake as a predictor of large joint destruction in patients with rheumatoid arthritis
    Yukio Yonemoto
    Koichi Okamura
    Kimihiko Takeuchi
    Tetsuya Kaneko
    Tsutomu Kobayashi
    Chisa Okura
    Yoshito Tsushima
    Kenji Takagishi
    Rheumatology International, 2016, 36 : 109 - 115
  • [22] PREDICTION OF LARGE JOINT DESTRUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS USING FDG-PET/CT
    Suto, T.
    Okamura, K.
    Yonemoto, Y.
    Okura, C.
    Tsushima, Y.
    Takagishi, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 999 - 1000
  • [23] THE INFLUENCE OF FATIGUE IN THE DEFINITION OF REMISSION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB
    Gaetano, J.
    Oliveira, S.
    Delgado Alves, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1131 - 1132
  • [24] CLINICAL AND ULTRASONOGRAPHIC ASSESSMENT OF EVOLUTION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOCILIZUMAB
    Rkain, Hanan
    Aktaou, Souad
    Raissouni, Hanae
    Hajjaj-Hassouni, Najia
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 402 - 402
  • [25] Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab
    Hoshi, Daisuke
    Nakajima, Ayako
    Inoue, Eisuke
    Shidara, Kumi
    Sato, Eri
    Kitahama, Mariko
    Seto, Yohei
    Tanaka, Eiichi
    Urano, Wako
    Ichikawa, Naomi
    Koseki, Yumi
    Momohara, Shigeki
    Taniguchi, Astuo
    Nishimoto, Norihiro
    Yamanaka, Hisashi
    MODERN RHEUMATOLOGY, 2012, 22 (01) : 122 - 127
  • [26] INDUCTION AND PROGRESSION OF SUBCUTANEOUS NODULOSIS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB
    Talotta, R.
    Batticciotto, A.
    Ditto, M. C.
    Gerardi, M. C.
    Ventura, D.
    Puttin, P. Sarzi
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1194 - 1194
  • [27] The clinical value of hematological markers in rheumatoid arthritis patients treated with tocilizumab
    Zhou, Li
    Xiao, Dong-Mei
    Qin, Wen
    Xie, Bin-Hua
    Wang, Ting-Hui
    Huang, Hua
    Zhao, Bao-Jing
    Han, Xi
    Sun, Qing-Qing
    Wu, Xiu-Di
    Cen, Han
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (05)
  • [28] Manubriosternal joint destruction with a rheumatoid nodule in rheumatoid arthritis
    Zoshima, Takeshi
    RHEUMATOLOGY, 2025,
  • [29] Predictive factors related to shoulder joint destruction in rheumatoid arthritis patients treated with biologics: A prospective study
    Yonemoto, Yukio
    Okamura, Koichi
    Kobayashi, Tsutomu
    Kaneko, Tetsuya
    Okura, Chisa
    Suto, Takahito
    Tachibana, Masahiro
    Tsushima, Yoshito
    Takagishi, Kenji
    MODERN RHEUMATOLOGY, 2017, 27 (04) : 587 - 592
  • [30] Immunogenicity of tocilizumab in patients with rheumatoid arthritis
    Sigaux, Johanna
    Hamze, Moustafa
    Daien, Claire
    Morel, Jacques
    Krzysiek, Roman
    Pallardy, Marc
    Maillere, Bernard
    Mariette, Xavier
    Miceli-Richard, Corinne
    JOINT BONE SPINE, 2017, 84 (01) : 39 - 45
12345